Asia Pacific Life Science Analytics Market By Component (Services and Software), By Application (Sales & Marketing Support, Research and Development (R&D), Pharmacovigilance, Supply Chain Analytics and Regulatory Compliance), By End User (Pharmaceutical, Medical Devices, Biotechnology and Other End Users), By Delivery Mode (On-Premise and On-demand), By Type (Descriptive, Predictive, Reporting and Prescriptive), By Country, Industry Analysis and Forecast, 2020 - 2026
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Life Science Analytics Market
Market Report Description
The Asia Pacific Life Science Analytics Market would witness market growth of 10.2% CAGR during the forecast period (2020-2026). Analytics platforms have not up till now reached the level of complete maturity necessary to act as a separate enterprise solution and these are still seen as modest assets within pharmaceutical companies. As the surge in the volume of data delivered through the new biological, clinical process, chemical, epidemiological, economic, and some other channels endures to grow, a novel era of analytics is evolving with more demand for analytics compute services. The analytics service supplier landscape external to the pharmaceutical companies is various and will keep growing till pharma itself catches up with some other industries.
Life science businesses are delicate. Precise risk assessment can be helpful to decrease the spread of epidemics, increase the expectancy of life, and avert mortalities among other aids. The life sciences industry is in a complex position. While on the one hand, it is dealing with challenges such as improving services, cost-reduction and being patient-centric.
The aids of analytics in life sciences are established in important areas like early detection of treatment as well as patterns of treatment, managing the intent of the patient to real results, and most prominently accomplishing the operational superiority to boost over the intellectual journey of patient centricity.
Based on Component, the market is segmented into Services and Software. Based on Application, the market is segmented into Sales & Marketing Support, Research and Development (R&D), Pharmacovigilance, Supply Chain Analytics and Regulatory Compliance. Based on End User, the market is segmented into Pharmaceutical, Medical Devices, Biotechnology and Other End Users. Based on Delivery Mode, the market is segmented into On-Premise and On-demand. Based on Type, the market is segmented into Descriptive, Predictive, Reporting and Prescriptive. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, IBM Corporation, Microsoft Corporation, Accenture PLC, Cognizant Technology Solutions Corporation, Infosys Limited, IQVIA Holdings, Inc., AllScripts Healthcare Solutions, Inc., Cerner Corporation and SAS Institute, Inc.
Scope of the Study
Market Segments Covered in the Report:
- Sales & Marketing Support
- Research and Development (R&D)
- Supply Chain Analytics
- Regulatory Compliance
By End User
- Medical Devices
- Other End Users
By Delivery Mode
- South Korea
- Rest of Asia Pacific
- Oracle Corporation
- IBM Corporation
- Microsoft Corporation
- Accenture PLC
- Cognizant Technology Solutions Corporation
- Infosys Limited
- IQVIA Holdings, Inc.
- AllScripts Healthcare Solutions, Inc.
- Cerner Corporation
- SAS Institute, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free